LifeCycle Pharma Receives US Patent for its MeltDose Technology
LifeCycle Pharma A/S announced the issuance of a patent for its MeltDose® Technology by the US Patent and Trademark Office, US Patent No. 7,217,431. The patent covers the method of making a particulate material containing a drug substance with low aqueous solubility, using a unique controlled agglomeration process. The issue of the MeltDose® patent does not change the company's financial expectations for 2007.
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.